Medicinal flowers. XXXI. Acylated oleanane-type triterpene saponins, sasanquasaponins I-V, with antiallergic activity from the flower buds of Camellia sasanqua

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 12, 2010, Pages 1617-1621

  Matsuda, Hisashi ^a   Nakamura, Seikou ^a   Fujimoto, Katsuyoshi ^a   Moriuchi, Ryo ^a   Kimura, Yuta ^a   Ikoma, Noriko ^a   Hata, Yuki ^a   Muraoka, Osamu ^b   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

Antiallergic activity; Camellia sasanqua; Degranulation inhibitor; Medicinal flower; Rat basophile leukemia 2H3 cell; Sasanquasaponin

Indexed keywords

ANTIALLERGIC AGENT; BETA N ACETYLHEXOSAMINIDASE; KETOTIFEN FUMARATE; PRIMULAGENIN A; SAPONIN; SASANQUASAPONIN I; SASANQUASAPONIN II; SASANQUASAPONIN III; SASANQUASAPONIN IV; SASANQUASAPONIN V; TRANILAST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BASOPHIL DEGRANULATION; BUD; CAMELLIA SASANQUA; CELL LINE; CONTROLLED STUDY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; FLOWER; MEDICINAL PLANT; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-ALLERGIC AGENTS; BETA-N-ACETYLHEXOSAMINIDASES; CAMELLIA; CELL LINE, TUMOR; FLOWERS; LEUKEMIA, BASOPHILIC, ACUTE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; OLEANOLIC ACID; RATS; SAPONINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 78649871764     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1617     Document Type: Article

References (34)

1. Part XXX: Morikawa T., Wang L. B., Ninomiya K., Nakamura S., Matsuda H., Muraoka O., Wu L. J., Yoshikawa M., Chem. Pharm. Bull., 57, 853-859 (2009).
2. Yoshida T., Chou T., Maruyama Y., Okuda T., Chem. Pharm. Bull., 38, 2681-2686 (1990).
3. Saito N., Yokoi M., Yamaji M., Honda T., Phytochemistry, 26, 2761-2762 (1987).
4. Fujimori N., Ashihara H., Phytochemistry, 29, 3513-3516 (1990).
5. Yoshikawa M., Morikawa T., Fujiwara E., Ohgushi T., Asao Y., Matsuda H., Heterocycles, 55, 1653-1657 (2001).
6. Yoshikawa M., Morikawa T., Asao Y., Fujiwara E., Nakamura S., Matsuda H., Chem. Pharm. Bull., 55, 606-612 (2007).
7. Yoshikawa M., Morikawa T., Yamamoto K., Kato Y., Nagatomo A., Matsuda H., J. Nat. Prod., 68, 1360-1365 (2005).
8. Yoshikawa M., Nakamura S., Kato Y., Matsuhira K., Matsuda H., Chem. Pharm. Bull., 55, 598-605 (2007).
9. Yoshikawa M., Wang T., Sugimoto S., Nakamura S., Nagatomo A., Matsuda H., Harima S., Yakugaku Zasshi, 128, 141-151 (2008).
10. Yoshikawa M., Sugimoto S., Nakamura S., Matsuda H., Chem. Pharm. Bull., 56, 1297-1303 (2008).
11. Sugimoto S., Yoshikawa M., Nakamura S., Matsuda H., Heterocycles, 78, 1023-1029 (2009).
12. Yoshikawa M., Sugimoto S., Kato Y., Nakamura S., wang T., Yamashita C., Matsuda H., Chem. Biodiv., 6, 903-915 (2009).
13. Sugimoto S., Chi G., Kato Y., Nakamura S., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 57, 269-275 (2009).
14. Morikawa T., Nakamura S., Kato Y., Muraoka O., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 55, 293-298 (2007).
15. Ohtani K., Mavi S., Hostettmann K., Phytochemistry, 33, 83-86 (1993).
16. Kitagawa I., Yoshikawa M., Kobayashi K., Imakura Y., Im K. S., Ikenishi Y., Chem. Pharm. Bull., 28, 296-300 (1980).
17. 13C-NMR spectra of 1-5 were assigned with the aid of distortionless enhancement by polarization transfer (DEPT), double quantum filter correlation spectroscopy (DQF COSY), heteronuclear multiple quantum coherence spectroscopy (HMQC), and heteronuclear multiple bond connectivity spectroscopy (HMBC) experiments.
18. Jiang Z., Gallard J.-F., Adeline M.-T., Dumontet V., Tri M. V., Sévenet T., Païs M., J. Nat. Prod., 62, 873-876 (1999).
19. Morikawa T., Li X., Nisida E., Nakamura S., Ninomiya K., Matsuda H., Oda Y., Muraoka O., Yoshikawa M., Helv. Chim. Acta, 93, 573-587 (2010).
20. Shin M., Wang W., Nam K. I., Jo Y., Jung H. J., Im S. K., J. Nat. Prod., 66, 1351-1355 (2003).
21. Matsuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M., Bioorg. Med. Chem., 10, 3123-3128 (2002).
22. Matsuda H., Morikawa T., Tao J., Ueda K., Yoshikawa M., Chem. Pharm. Bull., 50, 208-215 (2002).
23. Morikawa T., Matsuda H., Toguchida I., Veda K., Yoshikawa M., J. Nat. Prod., 65, 1468-1474 (2002).
24. Morikawa T., Matsuda H., Sakamoto Y., Ueda K., Yoshikawa M., Chem. Pharm. Bull., 50, 1045-1049 (2002).
25. Morikawa T., Tao J., Ueda K., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 51, 62-67 (2003).
26. Tao J., Morikawa T., Ando S., Matsuda H., Yoshikawa M., Chem. Pharm. Bull., 51, 654-662 (2003).
27. Matsuda H., Morikawa T., Xie H., Yoshikawa M., Planta Med., 70, 847-855 (2003).
28. Matsuda H., Morikawa T., Mangi H., Yoshikawa M., Bioorg. Med. Chem. Lett., 13, 3197-3202 (2003).
29. Matsuda H., Tewtrakul S., Morikawa T., Nakamura S., Yoshikawa M., Bioorg. Med. Chem., 12, 5891-5989 (2004).
30. Sun B., Morikawa T., Matsuda H., Tewtrakal S., Wu L. J., Harima S., Yoshikawa M., J. Nat. Prod., 67, 1464-1469 (2004).
31. Morikawa T., Sun B., Matasuda H., Wu L. J., Harima S., Yoshikawa M., Chem. Pharm. Bull., 52, 1194-1199 (2004).
32. Xu F., Matsuda H., Hata H., Sugawara K., Nakamura S., Yoshikawa M., Chem. Pharm. Bull., 57, 1089-1095 (2009).
33. Yoshikawa M., Shimada H., Komatsu H., Sakurama T., Nishida N., Shimoda H., Matsuda H., Tani T., Chem. Pharm. Bull., 45, 877-882 (1997).
34. Yoshizumi S., Murakami T., Kadoya M., Matsuda H., Yoshikawa M., Yakugaku Zasshi, 118, 188-192 (1998).